Jamieson Wellness Inc. (TSE:JWEL) Director Tania M. Clarke Acquires 4,000 Shares

Jamieson Wellness Inc. (TSE:JWELGet Free Report) Director Tania M. Clarke purchased 4,000 shares of the business’s stock in a transaction dated Friday, May 24th. The shares were purchased at an average price of C$26.47 per share, with a total value of C$105,888.00.

Jamieson Wellness Price Performance

TSE:JWEL opened at C$26.15 on Tuesday. Jamieson Wellness Inc. has a 52-week low of C$22.10 and a 52-week high of C$32.41. The stock has a fifty day moving average of C$26.24 and a 200 day moving average of C$28.76. The company has a debt-to-equity ratio of 95.32, a quick ratio of 1.08 and a current ratio of 3.23. The firm has a market capitalization of C$1.08 billion, a price-to-earnings ratio of 31.89 and a beta of 0.58.

Jamieson Wellness Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, June 14th. Stockholders of record on Friday, June 14th will be given a dividend of $0.19 per share. The ex-dividend date of this dividend is Friday, May 31st. This represents a $0.76 dividend on an annualized basis and a dividend yield of 2.91%. Jamieson Wellness’s dividend payout ratio (DPR) is presently 92.68%.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the stock. Eight Capital cut their target price on shares of Jamieson Wellness from C$46.00 to C$38.00 in a research report on Thursday, March 14th. Stifel Nicolaus reduced their price objective on shares of Jamieson Wellness from C$45.00 to C$42.00 in a research note on Thursday, March 14th. Royal Bank of Canada increased their target price on Jamieson Wellness from C$31.00 to C$32.00 in a research report on Friday, May 10th. National Bankshares reduced their price target on Jamieson Wellness from C$38.50 to C$36.00 in a research report on Thursday, March 14th. Finally, TD Securities dropped their price objective on Jamieson Wellness from C$39.00 to C$32.00 in a report on Friday, May 10th. Two investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of C$34.69.

View Our Latest Analysis on Jamieson Wellness

Jamieson Wellness Company Profile

(Get Free Report)

Jamieson Wellness Inc, together with its subsidiaries, develops, manufactures, distributes, markets, and sells of branded and customer branded health products for humans in Canada, the United States, China and internationally. It operates through two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment manufactures, distributes, and markets branded natural health products including vitamins, minerals, and supplements.

Further Reading

Receive News & Ratings for Jamieson Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jamieson Wellness and related companies with MarketBeat.com's FREE daily email newsletter.